INMB - INmune Bio GAAP EPS of -$0.36 May, 03 2023 04:48 PM INmune Bio Inc. 2023-05-03 16:48:33 ET INmune Bio press release ( NASDAQ: INMB ): Q1 GAAP EPS of -$0.36. As of March 31, 2023, the Company had cash and cash equivalents of approximately $51.0 million. For further details see: INmune Bio GAAP EPS of -$0.36